Last update 25 Jun 2026
Q-Med International Trading Shanghai Co. Ltd.

Q-Med International Trading Shanghai Co. Ltd.

Private Company|2006|Shanghai Shi, China|
www.restylane.com.cn

Overview

Tags

Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
IL-31RA(interleukin 31 receptor A)1

Related

1
Drugs associated with Q-Med International Trading Shanghai Co. Ltd.
Nemolizumab
Target
IL-31RA
Mechanism
IL-31RA inhibitors
Active Org.
Galderma Holding SAGalderma Holding SA [+9]
Originator Org.
Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Active Indication
Moderate Atopic Dermatitis [+7]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date28 Mar 2022
100 Clinical Results associated with Q-Med International Trading Shanghai Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Q-Med International Trading Shanghai Co. Ltd.
Login to view more data
100 Deals associated with Q-Med International Trading Shanghai Co. Ltd.
Login to view more data
100 Translational Medicine associated with Q-Med International Trading Shanghai Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Botulinum toxin A (Q-Med)
 ( SNAP25 )		Facial wrinkles
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free